Gainify
RT @TheAlphaThought: 1) Dividends are key to steady returns.

@gainify_io lets you analyze per-share payouts, track dividend streak consistency, review historical growth, and explore projected increases.

Find reliable income-generating stocks to strengthen your portfolio with ease. https://t.co/gzBJkzfZMC
tweet

Dimitry Nakhla | Babylon Capital®
15 Quality Stocks FCF CAGR >12% Last 10 Years | Years of Growth in Those 10 Years 💸

1. $MSFT +12% | 8/10
2. $ICE +12% | 9/10
3. $FICO +14% | 7/10
4. $CDNS +15% | 9/10
5. $MA +16% | 9/10
6. $INTU +17% | 9/10
7. $SPGI +18% | 10/10
8. $CPRT +19% | 8/10
9. $GOOG +20% | 7/10
10. $CSU +21% | 9/10
11. $MSCI +23% | 10/10
12. $LRCX +25% | 7/10
13. $FTNT +27% | 10/10
14. $META +30% | 8/10
15. $NVDA +54% | 9/10
tweet

Evan
RT @StockMKTNewz: GET READY FOR ANOTHER CRAZY WEEK AHEAD IN THE STOCK MARKET

Here's a full catalyst watch to help you get prepared

A thread 🧵⬇️ https://t.co/roF0fsnfW6
tweet

naiive
BlackRock when everyone is selling https://t.co/YYkByGgHga
tweet

naiive
First day 3 Years
in Crypto in Crypto
https://t.co/YJxwXd3PuB
tweet

naiive
SeptemBounce
Uptober
Pumvember
Bullcember

then Pamp ... JanMoonAry.... https://t.co/YA9RphrQJF
tweet

naiive
BREAKING : Michael Saylor just bought another 4,000 BTC for $0.5B https://t.co/WMC45uldxN
tweet

Gainify
DIVIDEND WATCH: Is $NVO becoming one of the best dividend stocks right now?

➡️ DPS set to grow 10% annually over the next 3 years
➡️ Solid current yield of 3.3%

Growth + income = a powerful combo. https://t.co/NLifpc3v1X
tweet

Yellowbrick Investing
$UTHR

$UTHR don´t really know the name but putting together some basics at roughly 440/450:
20 bln market cap with 5 bln in net cash
-> 15 bln EV (excluded the post-earnings buyback here)
3.2 bln of existing sales with 1.25 bln of NOPAT (annualizing H1 2025)
- IPF should be very incremental to earnings, ChatGPT seeing 3-4 bln in sales with 25% penetration (which sounds low for a high unmet need market?). That should hit totally different towards PnL than the first/current 3 bln, no?

Ton of stuff I know absolutely nothing(!) about here, but that does not look like a challenging valuation?

Feels like this will just be the next ALNY/INSM large cap going up every day and beloved by generalists?

What am I missing? Whats breaking the case here? - AnotherBioInvestor
tweet

naiive
Everyone on X : " just buy the dip "

me: https://t.co/V4q1Cn2GDX
tweet